Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use technology utilizing light and its remittance to view suspicious moles and lesions up to two millimeters (mm) beneath in a pain-free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.


TSXV:MDX - Post by User

Comment by hopefullon Feb 09, 2021 7:35am
67 Views
Post# 32510391

RE:RE:RE:RE:RE:RE:RE:Napkin math

RE:RE:RE:RE:RE:RE:RE:Napkin mathYou have mentioned before to look at the market cap and stated that it is undervalued. If that is the case why doesn’t Medx start to release more information to generate an increase in share price which would change the market cap or....... not favouring increase the number of shares. Either way Medx seems to be caught in a ebb of stagnant water noble meet timelines of what has been previously stated nor provide responsible updates.
please explain how you think market cap has any bearing on the performance of Medx. From what we can observe from the outside is Mike’s doing all the work.
<< Previous
Bullboard Posts
Next >>